1. Malandrakis, P. Sustained marrow and imaging MRD negativity can lead to lenalidomide discontinuation following ASCT in multiple myeloma: Updated results from a prospective cohort study. Presented ...
From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...
In this video, Leo I. Gordon, MD, FACP, discusses how a deeper understanding of minimal residual disease may lead to better care for patients with diffuse large B-cell lymphoma.
AntMind, a climate-tech startup, aims to transform forestry byproducts into renewable energy while simultaneously ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
This intense storm was partly responsible for warming up northern Canada and creating what we call a stratospheric warming ...
T-DXd significantly improved IDFS and reduced the risk of invasive disease or death by 53% compared to T-DM1 in high-risk, HER2-positive breast cancer patients. The trial demonstrated superior ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based ...
California now bans cat declawing except for medical reasons, joining a growing list of states protecting feline welfare.
CGI Inc. shows strong Q3 growth, solid cash flow, key contract wins, and attractive valuation at 13.6x earnings. Learn why ...
MedPage Today on MSN
A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy
Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...
The Housing Development Economic Feasibility and Implementation Analysis for Palo Alto has concluded that not a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results